10% Owner Opaleye Management Inc. Buys $2.86M in Sol-Gel Technologies Shares
SLGL has more than doubled off its 52-week low of $4.018 on elevated volume (2.0× avg).
Summary
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd., reported an open market purchase of $2.86 million in company shares, signaling strong conviction.
Key Events · Ownership and Investor Activity · SLGL
-
Major Open Market Purchase
Opaleye Management Inc., a 10% owner, acquired 39,665 ordinary shares for a total of $2,855,880 in open market transactions on March 24, 2026.
-
Strong Investor Conviction
This purchase represents a significant investment by a major shareholder, indicating strong confidence in Sol-Gel Technologies' future prospects.
-
Post-Offering and Earnings Context
The acquisition follows the company's recent positive 2025 earnings report and a successfully priced oversubscribed offering, suggesting the investor is capitalizing on recent positive momentum.
Analysis · SLGL · Life Sciences
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd., reported a substantial open market purchase of nearly $2.86 million in company shares. This significant acquisition, representing over 1.2% of the company's market capitalization, signals strong conviction from a major institutional investor. The timing of this purchase, following closely on the heels of the company's positive 2025 earnings report and a recently priced oversubscribed offering, suggests the investor sees continued upside potential after these recent positive developments.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLGL was trading at $80.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $222.9M. The 52-week trading range was $4.02 to $97.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.